Colorectal cancer is the fourth commonest form of cancer worldwide with an estimated 678 000 new cases diagnosed in 1985 . High incidence rates are found in Western Europe, North America and Australasia and intermediate rates in Eastern Europe, with the lowest rates found in sub-Saharan Africa (Boyle et al., 1985) . The disease is not uniformly fatal although there are large differences in survival according to stage of disease. In advanced colorectal cancer in which curative resection is possible, 5 year survival in Dukes' B is 45%, which drops to 30% in Dukes' C (Morson, 1979) . Five year survival in resected Dukes' A is around 80% and survival following simple resection of an adenomatous pedunculated polyp containing carcinoma in situ (or severe dysplasia) or intramucosal carcinoma is generally close to 100%. It is estimated that there are, however, still 394 000 deaths annually from colorectal cancer worldwide (Pisani et al., 1993 Allison et al., 1990) and by detecting colorectal cancers at stages in the natural history at which lesions bleed which leads to a short lead-time and the requirement for frequent testing. Rehydration of the slides results in increased positivity but also an increased number of colonoscopies and a decreased specificity of the test. The costs must be weighed against the benefits before public health policy on this topic is formulated (Mandel et al., 1993) .
Until a randomised controlled trial is undertaken and reported, the efficacy of flexible sigmoidoscopy as a screening test for preventing death from colorectal cancer will remain unproven. However, there is now a good deal of evidence supporting infrequent sigmoidoscopy as a potentially effective screening modality for colorectal cancer. Impressive reductions in rectal cancer and cancer of the proximal colon have been reported from demonstration studies: 85% reduction in 21 000 subjects undergoing 'clearing' proctosigmoidoscopy followed by annual proctosigmoidoscopy with removal of all lesions detected (Gilbertson and Nelns, 1978) ; 70% reduction in risk of colorectal cancer for 10 years following sigmoidoscopy (Selby et al., 1992); 80% reduction in incidence following examination mostly performed by flexible sigmoidoscopy (Newcomb et al., 1992) ; and an 85% reduction of rectal cancers achieved by the removal of adenomas (Atkin et al., 1992) . Although the initial examination may be expensive, there is an advantage that polyps may be removed at the time of the initial procedure and no follow-up visits will be required. Use of a 65 cm flexible sigmoidoscope appears to be the most effective proposition at the present time since this avoids the more complicated colonoscopy and yet still covers the region of the large bowel where two-thirds of cancers arise.
The natural history and the role of several risk factors in the aetiology of colorectal cancer are becoming more clearly understood (Fearon and Vogelstein, 1990; Morotomi et al., 1990) and the genetic events involved in colorectal cancer susceptibility are being uncovered with increasing frequency (Bodmer et al., 1987; Hall et al., 1994) . The recent rate of progress in our understanding of the genetics of colorectal cancer is impressive (Bishop and Thomas, 1990; Bishop and Hall, 1994 (Farmer et al., 1993) .
Prospects for prevention of colorectal cancer death are much brighter than even 10 years ago (Zaridze. 1983) . Large randomi'sed trials of screening with flexible sigmoidoscopy are very important and there is a strong case for chemoprevention trials using aspirin (or another NSAID) and antioxidants (vitamin E, frcarotene. vitamin C). Successful outcomes to these trials could see strategies to prevent the majority of colorectal cancer deaths available to the general population within a decade. It could also be important to follow up the consistent observations of protective effects of hormone replacement therapy in colorectal cancer. where the risk may be halved in association with six or more years of use (Calle et al.. 1995) .
Coupled with developments in genetics, and even treatment (Cunningham and Findlay. 1993) . colorectal cancer may emerge as the first major neoplasm which turns out to be preventable allying successful treatment with successful prevention strategies using prescription (screening and chemoprevention) rather than proscription ('Thou shalt not smoke or eat a high-fat diet'). A united funding policy and an internationally co-ordinated research programme would serve to accelerate this potential.
